CD8A and melanoma: To assess the effect of ipilimumab on overall gene expression in CD4+ and CD8+ T cells in vivo, microarray analysis was conducted on T cells purified by flow cytometry from PBMCs collected from 12 resected melanoma patients pre- and 6-month post-ipilimumab treatment (Additional file 1: Table S1).